Dementia with Lewy Bodies
📧 Sign up to get email alerts when something new happens for Dementia with Lewy Bodies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis [NA]
A single-center clinical trial is evaluating gustatory function in idiopathic Parkinson's disease and Lewy body disease using gustatory evok…
-
CLINICAL_TRIALS research · 2024-04-01Clinical Trial Update: In-Home Care for Patients With PSP and Related Disorders [NA]
A completed clinical trial evaluating in-home care for patients with PSP and related disorders, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Trial of Ondansetron as a Parkinson's HAllucinations Treatment [Phase 2]
A Phase 2 clinical trial evaluating ondansetron for treating Parkinson's hallucinations and related dementia with Lewy bodies symptoms.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research [NA]
A completed clinical trial evaluating a relational recruitment and engagement intervention for cognitive aging research; results were posted…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial [Phase 2]
A Phase IIa multicentre randomized double-blind trial assessing ambroxol in dementia with Lewy bodies is ongoing or in early stages, with un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital [Phase 3]
Phase 3 clinical trial update evaluating improved access to medical imaging for geriatric patients at The Royal Ottawa Hospital, focusing on…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia [NA]
A completed clinical trial studying peer mentor support and caregiver education for Lewy body-related dementias; results posted in 2023.
-
FDA approval · 2022-11-30FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
FDA approved a supplemental application for DATSCAN (IOFLUPANE I-123) by Medi-Physics Inc. dba GE Healthcare, indicating an update to the la…
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies [Phase 2]
Phase 2 trial evaluating efficacy, safety, and tolerability of E2027 (Irsenontrine) in participants with Dementia with Lewy Bodies has compl…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies [Phase 2]
Phase 2 trial update evaluating bosutinib’s safety, tolerability, biomarkers, and clinical outcomes in Dementia with Lewy Bodies.
-
FDA approval · 2022-03-30FDA Approved: IOFLUPANE I 123 — Original Application (Curium US LLC)
The FDA approved IOFLUPANE I-123 (IOFLUPANE I-123) from Curium US LLC in an Original Application as a dopamine transporter imaging agent for…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies [Phase 2]
Phase 2 trial assessing cognitive effects of the oral p38 alpha kinase inhibitor neflamapimod in dementia with Lewy bodies has completed; re…
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) [Phase 2]
Phase 2 clinical trial evaluating nelotanserin for REM Sleep Behavior Disorder in patients with dementia-related conditions has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia [Phase 2]
Phase 2 clinical trial evaluating intepirdine (RVT-101) for gait and balance in dementia subjects has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Movement and Music Intervention for Individuals With Dementia [NA]
A completed clinical trial evaluating movement and music intervention for individuals with dementia.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study [Phase 2]
Phase 2 clinical trial evaluating intepirdine (RVT-101) for dementia with Lewy bodies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery
A completed clinical trial (NCT02550626) investigated the relationship between alpha-synucleinopathy-related non-motor symptoms and postoper…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
A completed clinical trial sponsored by the University of Pennsylvania evaluated care coordination from hospital to home for cognitively imp…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
This post-marketing surveillance study evaluates the long-term safety and efficacy of Aricept (donepezil hydrochloride) in patients with dem…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies [NA]
A completed clinical trial explored stimulation of the Nucleus Basalis of Meynert to address cognitive disorders in Dementia with Lewy bodie…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension [Phase 2, Phase 3]
The HEADWAY-DLB extension trial of intepirdine (RVT-101) in dementia with Lewy bodies has been terminated. It was a long-term extension of a…
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Optical Coherence Tomography in Cerebral Amyloidosis
This ClinicalTrials.gov entry describes a study evaluating optical coherence tomography in cerebral amyloidosis, including Alzheimer’s disea…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Deep Brain Stimulation for Patients With Dementia With Lewy Bodies [NA]
This clinical trial update notes that the study evaluating deep brain stimulation for patients with Dementia with Lewy Bodies has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease [NA]
This clinical trial update indicates that the treadmill walking study involving individuals with Huntington's disease and dementia with Lewy…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Oculomotor Testing in the Differential Diagnosis of Dementia [Phase 3]
Phase 3 clinical trial evaluating oculomotor testing to differentiate dementia with Lewy bodies from Alzheimer's disease; status completed.